BLOG
Writing from Valar Labs on AI, pathology and cancer care.
Blog · October 28, 2026
Towards a cancer superintelligence
Every cancer patient’s tumor is examined under a microscope, and it holds far more than any one person can see. Why we built AI to read all of it, and why the goal is to inform every decision in cancer care.
Read Post
Engineering · March 25, 2026
5 Years, 7 Engineers, No Cloud: How We Build Cancer Diagnostics on Tinyboxes
A technical account of how a seven-person team builds validated AI cancer diagnostics on local hardware, with custom tools across the entire stack.
Read Post
Blog · May 22, 2024
Announcing Our $22 Million Series A to Accelerate AI in Precision Oncology
Co-led by DCVC and a16z, this funding will support the advancement of Vesta, world’s first AI test to predict treatment response in bladder cancer, and catalyze expansion in other cancers.
Read Post
